The Value of Breast-Conserving Surgery Combined with Neoadjuvant Therapy for Breast Cancer

  • Zhu Wu Jingzhou First People's Hospital
  • Zhuo Wang Jingzhou First People's Hospital
  • Qingqing Ye Jingzhou First People's Hospital
  • Rong Fan Jingzhou First People's Hospital
DOI: https://doi.org/10.18686/aem.v12i1.355
Keywords: Breast Cancer, Breast-Conserving Surgery, Neoadjuvant Therapy, Value Analysis

Abstract

Objective: To observe the efficacy of different methods in the treatment of breast cancer disease. Methods: A sample of 78 patients attending the clinic from 2020.8 to 2023.1 was randomly selected and divided into groups A and B. Thirty-nine patients each underwent conventional breast-conserving surgery and group B combined with neoadjuvant therapy to compare the effectiveness of treatment between the groups. Results: The overall efficiency of group B vs group A was 94.87% vs 71.79%, a significant difference (P < 0.05). Surgery-related indicators were better in Group B than in Group A (P < 0.05). Conclusion: Early intervention with breast-conserving surgery combined with neoadjuvant therapy is recommended for patients with breast cancer and has demonstrated high clinical value.

References

[1] Yuan S. L.,Chen Y.,Wang Y. Recent efficacy and prognosis analysis of plastic breast-conserving surgery for early breast cancer [J]. Chinese aesthetic medicine, 2022,31(12):33-35.

[2] Wang L. Effectiveness of plastic breast-conserving surgery in the treatment of early breast cancer[J]. China Medical Guide, 2022, 20(28):45-48.

[3] Wang JB, Zheng RS. Advances in neoadjuvant endocrine therapy for breast cancer[J]. Journal of Bengbu Medical College, 2009,34(11):1048-1050.
Published
2023-03-21
Issue
Vol 12, No 1(2023)
Section
Original Research Article

Copyright (c) 2023 Zhu Wu, Zhuo Wang, Qingqing Ye, Rong Fan

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear

Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.